StimCell Enegetics

StimCell Enegetics Interest Coverage

The Interest Coverage Ratio of StimCell Enegetics (STME) as of Oct 23, 2026 is -5.08. In the previous year, Interest Coverage Ratio was -9.44 — a change of -46.21% (higher).

Interest Coverage

-5.08

YoY

-46.21%

Last updated:

Interest Coverage Ratio of StimCell Enegetics is 2024 -5.08 . Interest Coverage Ratio of StimCell Enegetics was 2023 -9.44 . It decreases by -46.21% higher compared to the previous year.

The StimCell Enegetics Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
-53.48 USD
Jan 1, 2018
-137.10 USD
Jan 1, 2019
-62.18 USD
Jan 1, 2020
-49.21 USD
Jan 1, 2021
-20.99 USD
Jan 1, 2022
-26.14 USD
Jan 1, 2023
-9.44 USD
Jan 1, 2024
-5.08 USD
The StimCell Enegetics Interest Coverage history
YEARInterest CoverageYoY
-5.08-46.21%
-9.44-63.86%
-26.14+24.51%
-20.99-57.35%
-49.21-20.85%
-62.18-54.65%
-137.10+156.36%
-53.48+43.54%
-37.26+57.41%
-23.67—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

StimCell Enegetics Stock analysis

What does StimCell Enegetics do? Cell MedX Corp. makes money through its subsidiary Avyonce Cosmedics Inc., which resells spa technology and equipment to the beauty and wellness industry. Avyonce also markets eBalance Technology, used for micro current treatments targeting diabetes and related ailments, and conducts observational studies with this technology. The company provides continuing education for estheticians and healthcare professionals in medical aesthetics. Avyonce Cosmedics Inc. serves the beauty and wellness industry, focusing on professionals who use spa technology and equipment. The firm develops a family of devices based on eBalance Technology, which is applied in treatments for diabetes and related conditions. This technology is central to Avyonce's product offerings and educational services. Cell MedX Corp. operates as a development stage company with no full-time employees, relying on its subsidiary Avyonce to drive revenue. The company's business model centers on the commercialization of eBalance Technology through product sales, educational programs, and observational studies in the medical aesthetics sector. StimCell Enegetics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about StimCell Enegetics stock

Interest Coverage Ratio of StimCell Enegetics is -5.08 in 2024.

Interest Coverage Ratio of StimCell Enegetics changed from -9.44 to -5.08, representing a -46.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio StimCell Enegetics since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's StimCell Enegetics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — StimCell Enegetics

All Key Metrics — StimCell Enegetics